SUNITINIB TARO 25 MG Israël - Engels - Ministry of Health

sunitinib taro 25 mg

taro international ltd, israel - sunitinib - hard capsule - sunitinib 25 mg - sunitinib - sunitinib taro is indicated for:• treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. • treatment of advanced renal cell carcinoma.• treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.

SUNITINIB TARO 37.5 MG Israël - Engels - Ministry of Health

sunitinib taro 37.5 mg

taro international ltd, israel - sunitinib - hard capsule - sunitinib 37.5 mg - sunitinib - sunitinib taro is indicated for:• treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. • treatment of advanced renal cell carcinoma.• treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.

SUNITINIB TARO 50 MG Israël - Engels - Ministry of Health

sunitinib taro 50 mg

taro international ltd, israel - sunitinib - hard capsule - sunitinib 50 mg - sunitinib - sunitinib taro is indicated for:• treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. • treatment of advanced renal cell carcinoma.• treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.

Sunitinib Krka 12,5 mg hard caps. België - Engels - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sunitinib krka 12,5 mg hard caps.

krka d.d. novo mesto d.d. - sunitinib malate 16,71 mg - eq. sunitinib 12,5 mg - capsule, hard - 12,5 mg - sunitinib malate 16.71 mg - sunitinib

Sunitinib Krka 25 mg hard caps. België - Engels - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sunitinib krka 25 mg hard caps.

krka d.d. novo mesto d.d. - sunitinib malate 33,41 mg - eq. sunitinib 25 mg - capsule, hard - 25 mg - sunitinib malate 33.41 mg - sunitinib

Sunitinib Krka 50 mg hard caps. België - Engels - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sunitinib krka 50 mg hard caps.

krka d.d. novo mesto d.d. - sunitinib malate 66,83 mg - eq. sunitinib 50 mg - capsule, hard - 50 mg - sunitinib malate 66.83 mg - sunitinib

Sunitinib Pharmacare 12.5 mg hard capsules Malta - Engels - Medicines Authority

sunitinib pharmacare 12.5 mg hard capsules

pharmacare premium limited hhf 003 halfar industrial estate birzebbugia bbg 3000, malta - hard capsule - sunitinib 12.5 mg - antineoplastic agents

Sunitinib Pharmacare 25 mg hard capsules Malta - Engels - Medicines Authority

sunitinib pharmacare 25 mg hard capsules

pharmacare premium limited hhf 003 halfar industrial estate birzebbugia bbg 3000, malta - hard capsule - sunitinib 25 mg - antineoplastic agents

Sunitinib Pharmacare 37.5 mg hard capsules Malta - Engels - Medicines Authority

sunitinib pharmacare 37.5 mg hard capsules

pharmacare premium limited hhf 003 halfar industrial estate birzebbugia bbg 3000, malta - hard capsule - sunitinib 37.5 mg - antineoplastic agents

Sunitinib Pharmacare 50 mg hard capsules Malta - Engels - Medicines Authority

sunitinib pharmacare 50 mg hard capsules

pharmacare premium limited hhf 003 halfar industrial estate birzebbugia bbg 3000, malta - hard capsule - sunitinib 50 mg - antineoplastic agents